SUBSCRIBE
SUBSCRIBE

Gina Hagler

Policy
Overview: The Lower Drug Costs Now Act of 2019 and the American Pharmaceutical Industry
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (cited as the Lower Drug Costs Now Act of 2019), is a bill before the House that is intended to make prescription drugs more affordable for those in the Medicare program.
November 12, 2019
 · 
3 min read
 · 
Gina Hagler
Brexit Pharma Updates
Several events relevant to UK pharma have occurred recently. Here’s a look.
October 21, 2019
 · 
2 min read
 · 
Gina Hagler
You deserve a raise. Find and apply for higher paying jobs on BioSpace. Browse Jobs
Policy
What’s at Stake for the U.K. Pharma Industry in a No-Deal Brexit?
The U.K. government is working to ensure adequate quantities of medications and medical devices are on hand for the transition period that will follow any form of Brexit. As for the life sciences and biotech industries – it’s become increasingly clear they face acute disruption as a result of this period of uncertainty.
October 10, 2019
 · 
4 min read
 · 
Gina Hagler
Policy
What Do the J&J and Purdue Pharma Outcomes Mean to the Pharma Industry?
Oklahoma was the first state to file suit against opioid manufacturers. The success of their legal strategy will have a significant impact on the opioid–and pharmaceutical–industry going forward.
September 30, 2019
 · 
5 min read
 · 
Gina Hagler
Advances in the Treatment of Chronic Asthma
A therapy that leads to fewer asthma attacks while reducing the need for corticosteroids is ideal, especially for those who continue to have severe symptoms while using traditional therapies. That’s where biologics come in.
September 12, 2019
 · 
5 min read
 · 
Gina Hagler
Courtesy of Getty Images
Genetown
New Therapies for Blood Cancers Hold Promise
Blood cancer is actually a term applied to three different types of cancer – leukemia, lymphoma, and myeloma. For centuries, these cancers had virtually no possibility of survival. Even as recently as the 1960s, the five-year survival rate for leukemia was 14%. By 2010, it had increased to 61%.
September 10, 2019
 · 
4 min read
 · 
Gina Hagler
Load More